Morning, Monday, 21st February 2022
This conference will examine next steps for vaccine research, development, and rollout.
Areas for discussion include:
- lessons that can be learned from the COVID-19 vaccination programme to inform the development of future vaccines and treatments
- the role, development, and use of booster and second generation COVID-19 vaccines as a fourth wave of COVID-19 spreads through Europe
- harnessing innovation within vaccinology to boost research and improve outcomes - learning from:
- the rapid rollout of Messenger RNA (mRNA) vaccines during the pandemic
- research partnerships developed across the public and private sector as a response to the pandemic
- priorities for delivering an effective malaria vaccination programme
- utilisation of global networks and supply chains that have been put in place during the pandemic
- learning from what has worked internationally
- the global rollout of COVID-19 vaccines, and ensuring new, innovative vaccines are accessible to all
There will also be an opportunity to assess priorities for action beyond the COVID-19 pandemic - looking at what has been learned that can be applied more widely to progress on vaccines and considering key issues for policy, regulation, and industry action.
We are pleased to be able to include keynote sessions on:
- Opportunities for taking forward recent achievements in vaccine research and development - with Dr Doug Brown, Chief Executive, British Society for Immunology
- Driving forward COVID-19 vaccine research and development - with Professor Andrew Ustianowski, National Clinical Lead, COVID Vaccine Research Programme, NIHR
- Global rollout and accessibility of COVID-19 vaccines and other innovative developments - with Dr Alejandro Cravioto, Chair, Strategic Advisory Group of Experts on Immunisation, WHO
The discussion is bringing together stakeholders with key policy officials who are due to attend from the DHSC; the MHRA; and the UK Health Security Agency.